OUR FIRM

Latest News

April 17, 2015

Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of William Tanner as a Managing Director and senior biotech research analyst.

Mr. Tanner will start work at Guggenheim in May 2015 in the firm’s New York office.

“Bill brings a wealth of biotech experience, in both investment and academic research, to our experienced and highly acclaimed healthcare team,” said Matthew Johnson, Senior Managing Director and Head of Equities at Guggenheim Securities. “Bill will join a healthcare research team that includes, on the equities side, Tony Butler in biopharmaceuticals and Louise Chen in specialty pharmaceuticals, and, on the government policy side, Rick Weissenstein in healthcare policy analysis in Washington.”

“Bill’s hiring is part of a highly-focused recent expansion of our research capabilities in such key sectors as tech-media-telecom, consumer, energy, and financial services,” said John Hervey, Senior Managing Director and Director of Research at Guggenheim Securities. “The goal is to continue to enhance our ability to help our clients achieve outstanding investment results.”

Mr. Tanner has worked nearly 20 years as a biotech analyst, including senior analyst roles at Leerink Swann and SG Cowen.

He holds a Bachelor of Science degree and a PhD in Physiology, both from Texas A&M University, as well as an MBA from Washington University’s Olin School of Business. Before embarking on his investment research career, Mr. Tanner worked as a post-doctoral research fellow at Monsanto Co. and as an NIH National Research Service Award fellow at Washington University School of Medicine.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.



April 19, 2022

Guggenheim Partners Accepting Applications for Fourth Network for Social Innovation Cohort

Guggenheim Partners is now accepting applications for the fourth cohort of the Network for Social Innovation (NSI), the firm’s venture philanthropy program designed to identify and support the growth of visionary non-profit organizations tackling some of the most challenging issues of our time.

Read More

April 18, 2022

Eric Mandl on Benefits of M&A for Shareholders and Consumers

Senior Managing Director Eric Mandl, Guggenheim Securities, discusses impacts and benefits of  takeover approaches on CNBC's TechCheck.

Watch Video

April 05, 2022

Guggenheim Securities Expands Technology Investment Banking Practice with the Addition of Jeff Bistrong

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jeff Bistrong has joined the firm as a Senior Managing Director in its Technology Investment Banking practice focusing on advising software and software-related technology companies. 

Read More